Long-term effects of Acoltremon for dry eye disease
Treatments studied
Part of Eyes & vision clinical trials.
This study tests a new medication called Acoltremon to see if it helps dry eye symptoms over a long period. If you've had dry eye for a while and used artificial tears, this trial might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with dry eye disease in the past 6 months.
- You have used or want to use artificial tears for your dry eye.
- You have at least a moderate amount of dry eye signs in one eye, like staining or low tear production.
- You have a dry eye symptom score of 40 or more out of 100.
- You are willing to stop using artificial tears for 24 hours before study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop for people who wear contact lenses and have dry eyes. The treatment may help reduce dryness and improve comfort while wearing lenses.
This study tests a new eye drop called TRYPTYR to see if it can improve quality of life and daily tasks for people with dry eye disease who are unhappy with their current treatment, Restasis. Participants will stop using Restasis and switch to TRYPTYR for about 4 weeks.
This trial tests a new eye drop (acoltre mon) to see if it helps people who have both dry eyes and nerve-related eye pain. The drops may increase tear production and reduce burning or light sensitivity.
This study compares two preservative-free eye drops, Artelac Complete MDO and Vismed Multi, to see how well they work and how safe they are for people with moderate to severe dry eye disease. If you have dry eye due to certain conditions (like Sjögren's syndrome) and standard eye drops haven't fully helped, this study may be an option.
This study tests a new eye drop called Acoltremon to see if it can relieve symptoms of moderate-to-severe dry eye disease. It may be a good option if you have had dry eye for at least 6 months and use artificial tears.
This trial studies an FDA-approved eye drop called acoltremon for treating dry eye disease. The goal is to see how well it works in everyday life, using patient surveys to measure symptom improvement.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.